XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Share-Based Compensation Expense
The following table presents the total share-based compensation expense resulting from equity awards and the 15.0% discount for the ESPP for the three months ended March 31, 2022 and 2021, which is included in compensation and benefits expense in the Condensed Consolidated Statements of Income:
 Three Months Ended March 31,
 20222021
 (in millions)
Share-based compensation expense before income taxes$25 $19 
Income tax benefit(6)(5)
Share-based compensation expense after income taxes$19 $14 
Summary of Restricted Stock Activity
The following table summarizes our restricted stock activity for the three months ended March 31, 2022:
Restricted Stock
 Number of AwardsWeighted-Average Grant Date Fair Value
Unvested at January 1, 20221,466,340 $106.16 
Granted10,221 199.30 
Vested(150,156)81.93 
Forfeited(15,953)109.42 
Unvested at March 31, 20221,310,452 $109.62 
Summary of PSU Activity
The following table summarizes our PSU activity for the three months ended March 31, 2022:
PSUs
One-Year ProgramThree-Year Program
 Number of Awards Weighted-Average Grant Date Fair ValueNumber of AwardsWeighted-Average Grant Date Fair Value
Unvested at January 1, 202249,734 $84.03 764,124 $135.04 
Granted— — 296,912 100.28 
Vested— — (578,614)97.70 
Forfeited(259)84.18 (399)148.47 
Unvested at March 31, 202249,475 $84.03 482,023 $158.45 
In the preceding table, the granted amount under the three year program reflects additional awards granted based on overachievement of performance parameters.
Summary of Stock Option Activity
A summary of stock option activity for the three months ended March 31, 2022 is as follows:
 
Number of Stock Options
Weighted-Average Exercise Price
Weighted-
Average
Remaining
Contractual
Term (in
years)
Aggregate
Intrinsic
Value (in
millions)
Outstanding at December 31, 2021268,817 $66.68 5.0$39 
Granted204,624 202.46 
Outstanding at March 31, 2022473,441 $125.36 6.9$30 
Exercisable at March 31, 2022268,817 $66.68 4.8$30